|

anti-GD2-800CW Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Princess Maxima Center for Pediatric Oncology1

Indications

  • Neuroblastoma1
  • Cancer1

Other1 trial

An Imaging Study of Anti-GD2-800CW in Patients With Neuroblastoma
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.